Unit 2 - Autonomics IV Flashcards

1
Q

explain synthesis of NE and E in adrenergic varicosity?

A

tyrosine (into cytoplasm) –> DOPA –> dopamine –> NE (vesicle) –> E (adrenal medulla)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

is NE or E a neurotransmitter or a neurohormone?

A

NE is a neurotransmitter

E is a neurohormone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the receptor interaction and effector cell response of NE and E?

A

second messenger amplification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how do D1 (dopamine) exert its second messenger effect?

A

stimulatory GPCR increases cAMP (like beta1/2/3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the adrenergic receptor excitation response?

A

constriction; Ca++ is made available to myofibrils and increases tension
-Ca++ from intracellular stores and/or transport from extracellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the adrenergic receptor inhibition response?

A

relaxation; Ca++ is made unavailable to myofibrils and reduces tension
-Ca++ is taken into intracellular stores and/or pumped out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the adrenergic receptor metabolic response?

A

activation of AC

  • increased liver glycogenolysis
  • increase in plasma glucose and FFA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the 3 ways specifically NE can “terminate” its action?

A
  1. neuronal reuptake (neuron-specific)
  2. effector cell uptake (non-specific and high capacity); extra-neuronal
  3. diffusion into capillaries
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the primary mechanism for terminating ACh? how is this different from NE?

A

enzymatic hydrolysis

-NE is reuptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what and where is MAO?

A

monoamine oxidase on mitochondria surface

-metabolize NE, E, and other exogenous adrenergic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what and where is COMT?

A

catechol-o-methyltransferase in cytoplasm of many cells, especially liver
-metabolize NE, E, and other exogenous adrenergic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the major metabolites of NE/E that are measured in urine/plasma?

A

normetanephrine, metanephrine, VMA, MHPG

-for diagnostic purposes (increased plasma metanephrine indicates pheochromocytoma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what does alpha-me-tyrosine do to modify chemical transmission?

A

decreases synthesis of NE (sympathetic) by decreasing pre-synaptic Ca++ influx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what does amphetamine do to modify chemical transmission?

A

increases release of NE (sympathetic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what does isoproterenol do to modify chemical transmission?

A

combine with receptor to increase NE (sympathetic)

-increases post-synaptic Ca++ influx and second messengers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what does propranolol do to modify chemical transmission?

A

antagonist to beta-receptor sites to decrease NE (sympathetic)
-decreases post-synaptic Ca++ influx and second messengers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what does cocaine do to modify chemical transmission?

A

increases termination step such that synapse activity increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is the prominent effector organ and response to receptor activation of beta 1?

A

heart - increased heart rate and force of contraction

kidney - renin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the prominent effector organ and response to receptor activation of beta 2?

A

arterioles (and arteries in skeletal muscle, coronary) - dilation
bronchial muscle - relaxation
pregnant uterus - N/A
several other sites - metabolic effects increase

20
Q

what is the prominent effector organ and response to receptor activation of beta 3?

A

adipose tissue (lipocytes) - lipolysis and thermogenesis increase

21
Q

what is the prominent effector organ and response to receptor activation of alpha 1?

A

arterioles in skin, mucosa, viscera, and kidney - constriction (resistance vessels)
veins - constriction
uterus and spleen - contraction

22
Q

what is the prominent effector organ and response to receptor activation of alpha 2?

A

presynaptic nerve endings - inhibit NE release and ACh release (gut)
postsynaptic in CNS - decreased peripheral sympathetic tone

23
Q

what is the prominent effector organ and response to receptor activation of D1?

A

renal, mesenteric, and cerebral arterioles - dilation

24
Q

what are the agonist/antagonist for a1?

A

agonist: phenylephrine
antagonist: prazosin

25
what are the agonist/antagonist for a2?
agonist: clonidine antagonist: yohimbine
26
what are the agonist/antagonist for D1?
agonist: fenoldopam antagonist: N/A
27
what are the agonist/antagonist for B1?
agonist: dobutamine antagonist: atenolol
28
what are the agonist/antagonist for B2?
agonist: albuterol antagonist: butoxamine
29
what are the agonist/antagonist for B3?
N/A for both
30
what are the agonist/antagonist for BOTH B1/2?
non-selective agonist: isoproterenol antagonist: propranolol
31
explain presynaptic and postsynaptic autoreceptor regulation of NE release?
stimulation of presynaptic a2 receptors inhibits NE release from nerve terminal, while drugs that block postsynaptic a2 receptors enhance NE release
32
how are organ responses to neurotransmitters/drugs determined?
by differences in receptor populations and receptor densities
33
explain the adrenergic receptors on skeletal muscle vessels?
have both a1 and B2 - low concentration: B2 (lower threshold, for physiologic response from sympathetic (adrenal) stimulation) --> relaxation and dilation - high concentration: a1 (higher threshold and "dominant constriction" only seen in high pharmacological EPI in lab or shock
34
what is the guiding principle to therapeutic drugs?
selectivity to get max effects with minimum side effects
35
for NE drugs, what does methylation at N seem to do?
NE (no methyl) is a1/2 (and less so B1) E (1 methyl) is a1/2 and B2 isoproterenol (3 methyl) is B1/2 only (no a1 b/c too much methyl)
36
what are the characteristic sympathomimetics for phenylephrine?
a1
37
what are the characteristic sympathomimetics for clinidine
a2
38
what are the characteristic sympathomimetics for NE?
a1, B1, (a2)
39
what are the characteristic sympathomimetics for E?
a1, B1, B2, (+a2)
40
what are the characteristic sympathomimetics for isoproterenol?
B1/2
41
what are the characteristic sympathomimetics for dopamine
D1, a1, B1
42
what are agonist potencies at adrenergic receptors for B1?
ISO > E >= NE > D
43
what are agonist potencies at adrenergic receptors for B2?
ISO > E >> NE >> D
44
what are agonist potencies at adrenergic receptors for a1?
E >= NE > D >> ISO
45
what are agonist potencies at adrenergic receptors for a2?
CLON > E >= NE >> ISO